secwatch.observer — SEC 8-K summary
======================================

Issuer:     YIELD10 BIOSCIENCE, INC. (—)
CIK:        0001121702
Form:       8-K
Filed at:   2024-03-29T23:59:59+00:00
Accession:  0001104659-24-041138
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Yield10 Bioscience receives Nasdaq deficiency notice; plans reverse stock split
-------------------------------------------------------------------------------

- Nasdaq staff notified Yield10 on March 26, 2024 it is ineligible for a second 180-day bid price compliance period due to insufficient stockholders' equity.
- Company does not meet the $5 million minimum stockholders' equity initial listing requirement for The Nasdaq Capital Market.
- Yield10 must present its views to the Nasdaq Panel by April 2, 2024 and plans a special shareholder meeting on April 26, 2024 to approve a reverse stock split.
- Stock continues trading on The Nasdaq Capital Market under symbol YTEN; no immediate delisting effect but compliance is uncertain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1121702/000110465924041138/0001104659-24-041138-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1121702/000110465924041138/tm2410151d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-041138

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer